Myocardial Computed Tomography Perfusion: One More Piece on The Board

Keywords
Coronary Artery Disease/physiopathology; Myocardial Ischemia; Tomography, Emission Computed/methods; Cineangiography/methods; Myocardial Perfusion, Imaging; Cardíac Catheterization; Exercise

The most appropriate way to evaluate patients with stable coronary artery disease (CAD) and the subsequent definition of the therapeutic approach has been the subject of debate in recent years. For several years the anatomical evaluation was considered sufficient to indicate myocardial revascularization. The emergence of several methods of non-invasive functional evaluation in clinical practice as well as data from observational studies demonstrating that there is a level of ischemia above which a revascularization strategy might result in benefit regarding cardiovascular events raised doubts whether an strategy based in coronary anatomic findings was the best option.^1,2 This questioning changed the paradigm of CAD evaluation. Although randomized clinical trials have failed to demonstrate that the extent of ischemia can determine which patients would benefit from a revascularization strategy,^3-5 the fact that the presence of moderate to severe ischemia is undeniably a marker of cardiovascular risk has lead functional evaluation to become a fundamental part in the management of patients with stable CAD.

In this context, Ker et al.⁶ in this edition of the Arquivos Brasileiros de Cardiologia evaluated 35 patients undergoing a simultaneous pharmacologic stress protocol of myocardial perfusion evaluation by computed tomography angiography (angio-CT) and single-photon emission computed tomography (SPECT) and compared the sensitivity of the methods using the presence of obstructive lesion evidenced by angio-CT greater than 50% as the gold standard for the presence of significant CAD.⁶

For the detection of obstructive CAD, the evaluation of myocardial perfusion by angio-CT had an area under the curve of 0.84 [confidence interval of 95% (95%CI): 0.67 to 0.94, P < 0.001]. SPECT had an area under the curve of 0.58 (95%CI: 0.40 to 0.74, P < 0.001). The sensitivity of SPECT to detect stenosis greater than 50% determined by angio-CT was 66%, with specificity of 50%. The sensitivity of perfusion angio-CT for detection of obstructive CAD was 93%, with specificity of 75% for the detection of absence of obstructive CAD by coronary angiography. In this study, false positives were considered when ischemia was present in a SPECT study with absence of obstructive CAD demonstrated by angio-CT. The authors concluded that the evaluation of myocardial perfusion by angio-CT presents satisfactory results in comparison with SPECT and that angio-CT can exclude false-positives of SPECT studies.

Although it is noteworthy the importance of developing new techniques to improve the evaluation of patients with CAD, it is fundamental to analyze which gold standard is used to test the accuracy of new diagnostic modalities. It is recognized that one of the limitations of the CT angiography is a specificity and positive predictive values suboptimal and a tendency to overestimate coronary lesions, being its sensitivity and negative predictive value excellent, providing necessary reassurance to exclude significant CAD,⁷ This limitation hinders a more adequate analysis of the diagnostic accuracy of the methods in this study, because the method used as a reference has its main limitation in predicting the presence of ischemia. In addition, anatomy evaluated by CT served as the gold standard for assessing the sensitivity and specificity of CT perfusion, that is, the tested method served as its own gold standard. In the CORE 320 study, cardiac catheterization was used as a reference for the diagnosis of CAD.⁸ In the CORE 320 study, the sensitivity of the angio-CT was 88% and the specificity was 55%, and SPECT presented sensitivity and specificity of 62% and 67%, respectively. Recently, catheterization associated with the measurement of fractional flow reserve (FFR) has been considered the method of choice for testing the diagnostic accuracy of other functional methods.

On the other hand, the presence of perfusion abnormalities in a functional test in the absence of obstructive CAD cannot always be categorized as "false-positive" results. It is increasingly recognized the role of coronary microcirculation dysfunction as a cause of ischemia and symptoms, generating the term microvascular angina.⁹ In this sense, methods that quantify the absolute coronary flow, such as positron emission tomography (PET), allow the quantification of myocardial flow and coronary flow reserve and can detect microvascular dysfunction. Unfortunately, cardiac PET is not a reality in Brazil.

Several publications in the literature do not demonstrate similar sensitivity and specificity of SPECT in comparison of what was determined by Ker et al.⁶ In a meta-analysis comparing SPECT, magnetic resonance and PET, using coronary catheterization without FFR as a gold standard, Jaarsma et al.¹⁰ reported a sensitivity of 84% and specificity of 61% for SPECT.¹⁰ In a recent meta-analysis that used coronary catheterization with FFR as a gold standard, the sensitivity and specificity of SPECT was 74% and 79%, respectively.¹¹

SPECT is an excellent non-invasive method for evaluating stable CAD, predominantly in patients with intermediate risk, or even in high-risk patients to helP in the planning of the therapeutic approach. In addition, it is possible to use exercise as the stress protocol in patients who have the adequate functional capacity and good clinical condition. It is well known that an exercise stress protocol is the method of choice to evaluate patients with suspected or established CAD.

In conclusion, to assess the accuracy of a diagnostic method, it is critical to choose the right gold standard. The use of anatomic criteria based on the angio-CT findings does not invalidate the study of Ker et al.,⁶ which opens a perspective for a new non-invasive technique that can assist in the proper management of patients with stable CAD, as well as creates the perspective of new research in this area. In the future, myocardial perfusion by angio-TC may be aggregated to the existing diagnostic armamentarium for the evaluation of patients with stable CAD, always taking into account the characteristic of the patient, and especially the functional capacity and possibility of exercise. In this context, non-invasive diagnostic methods that allow to perform exercise stress protocols should be the first choice.

• Short Editorial related to the article: Myocardial Perfusion by Coronary Computed Tomography in the Evaluation of Myocardial Ischemia Simultaneous Stress Protocol with SPECT

References

• ¹
  Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-91.
• ²
  Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, Sansing VV, Beller GA, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol. 2012;19(4):658-69.
• ³
  Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-16.
• ⁴
  BARI 2D Study GrouP , Frye RL, August P , Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503-15.
• ⁵
  Zellweger MJ, Maraun M, Osterhues HH, Keller U, Müller-Brand J, Jeger R, et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging. 2014;7(10):1001-10.
• ⁶
  Ker WS, Neves DGD, Magalhães TA, Santos AAS, Mesquita CT, Nacif MS. Myocardial perfusion by coronary computed tomography in the evaluation of myocardial ischemia: simultaneous stress protocol with SPECT. Arq Bras Cardiol. 2019; 113(6):1092-1101.
• ⁷
  Adamson PD, Newby DE, Hill CL, Coles A, Douglas PS, Fordyce CB. Comparison of International Guidelines for Assessment of Suspected Stable Angina: insights from the PROMISE and SCOT-HEART. JACC Cardiovasc Imaging. 2018;11(9):1301-10.
• ⁸
  George RT, Mehra VC, Chen MY, Kitagawa K, Arbab-Zadeh A, Miller JM, et al. Myocardial CT perfusion imaging and SPECT for the diagnosis of coronary artery disease: a head to head comparison from the CORE 320 multicenter diagnostic performance study. Radiology. 2014;272(2):407-16.
• ⁹
  Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35(17):1101-11.
• ¹⁰
  Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positrón emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012;59(19):1719-28.
• ¹¹
  Takx RA, Blomberg BA, El Aidi H, Habets J, de Jong PA, Nagel E, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging. 2015 Jan;8(1):pii:e002666.

Publication Dates

• Publication in this collection
  2 Dec 2019
• Date of issue
  Dec 2019